Quiz Summary
0 of 10 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 10 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 10
1. Question
Traditional cardiovascular risk factors include which of the following?
CorrectIncorrect -
Question 2 of 10
2. Question
What is the “psoriatic march?”
CorrectIncorrect -
Question 3 of 10
3. Question
Consensus guidelines recommend applying a multiplier of what magnitude to the CV risk calculation for all patients with rheumatic disease?
CorrectIncorrect -
Question 4 of 10
4. Question
Guidelines from the European League Against Rheumatism (EULAR) suggest that anti-TNF biologics should be avoided in patients with what level of heart failure?
CorrectIncorrect -
Question 5 of 10
5. Question
Which of the following has been identified as a risk factor for the development of metabolic syndrome?
CorrectIncorrect -
Question 6 of 10
6. Question
Which of the following antirheumatic therapies should be used with particular caution in patients with type 2 diabetes mellitus?
CorrectIncorrect -
Question 7 of 10
7. Question
What is currently the only biologic currently approved for the treatment of non-infectious uveitis?
CorrectIncorrect -
Question 8 of 10
8. Question
The Patient Health Questionnaire-2 assesses which two cardinal features of depression?
CorrectIncorrect -
Question 9 of 10
9. Question
Which of the following agents commonly used to treat PsA carry a black box warning against their use in patients with a history of depression and suicidal ideation?
CorrectIncorrect -
Question 10 of 10
10. Question
Which of the following biologic therapies FDA-approved for treatment of PsA is also approved for use in patients with ulcerative colitis and Crohn’s disease?
CorrectIncorrect